Donna

2013年7月30日星期二

1470nm EVLT Laser

VELAS 15W 1470nm

GIGAALASER is very proud to introduce the new generation of
our diode laser system---VELAS15D 1470nm surgical diode laser
system.
Why choose the VELAS15D?
The 1470nm wavelength corresponds to a peak of water absorbtion.
Due to the intracellular water of the vein wall and the water contend of blood, the 1470nm laser is ideal for venous diseases. VELAS15D offers you the optimum treatment solution in EVLT application.
With our EVLT accessories kit, VELAS15D could offer you the optimum treatment solution in the superficial reflux of the great saphenous veins, reticular veins, spider veins and vascular lesions. The VELAS15D minimize any post-operative pain and bruising, due to a 40 times or greater absorption coefficient in water compared to 810nm or 980nm lasers targeting hemoglobin. The patients will recovery quickly from the treatment to daily work.
With other kind of accessories, the VELAS15D could offer the ideal application in ENT, PLDD, Proctology, Gynaecology, Transcutaneous treatment, Dermatology and General surgery. Our laser systems have approved CE mark and ISO13485, so we can provide the best product with our best service for every customer.

http://www.gigaalaser.com/velas1470/

2013年7月29日星期一

Effects of Class IV Laser Therapy on Disease Impact and Function in Women with Fibromyalgia

Objectives:

This study evaluated the effects of Class IV laser therapy on pain, Fibromyalgia (FM) impact, and physical function in women diagnosed with FM.

Design:

The study was a double-blind, randomized control trial.

Setting:

Testing was completely at the university and Rheumatologist office and treatment was completed at a chiropractic clinic.

Participants:

Thirty-eight (38) women (52+/- 11 years; mean+/- standard deviation) with FM were randomly assigned to one of two treatment groups, laser heat therapy (LHT; n=20) or sham heat therapy (SHT; n=18).

Intervention:

Both groups received treatment twice a week for 4 weeks. Treatment consisted of application of LHT or SHT over seven tender points located across the neck, shoulders, and back. Treatment was blinded to women and was administered by a chiropractic physician for 7 minutes.

Outcome Measures:

Participants were evaluated before and after treatment for number and sensitivity of tender points, completed the FM Impact Questionnaire (FIQ) and the pain question of FIQ, and were measured for function using the continuous scale physical functional performance (CS-PFP) test. Data wew evaluated using repeated at P</=0.05.

Conclusions:

This study provides evidence that LHT may be a benificial modality for women with FM in order to improve pain and upper body range of motion, ultimately reducing the impact of FM.